Accendra Health, Inc. ACH
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 77.88% | -1,277.07% | 88.52% | 62.52% | 82.71% |
| Total Depreciation and Amortization | -40.76% | 6.41% | 106.68% | -53.40% | 49.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.31% | 5.05% | 59.69% | -10.59% | -111.53% |
| Change in Net Operating Assets | -81.92% | 170.00% | -128.18% | 1,095.86% | 146.82% |
| Cash from Operations | 33.05% | 48.07% | -173.44% | 139.52% | -558.71% |
| Capital Expenditure | 17.70% | -14.26% | -217.11% | 68.82% | 26.89% |
| Sale of Property, Plant, and Equipment | -12.93% | -84.13% | 291.95% | 33.95% | 1.35% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,944.80% | 222.99% | 98.34% | -223.01% | -17.06% |
| Cash from Investing | 118.45% | -157.94% | -81.08% | 822.19% | 25.42% |
| Total Debt Issued | -90.18% | 463.66% | -43.02% | -41.86% | -4.79% |
| Total Debt Repaid | 93.57% | -714.25% | 59.67% | 20.26% | 17.05% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 74.10% | -3,981.25% | 99.11% | -203.03% | 7,105.71% |
| Cash from Financing | 111.25% | -632.41% | 143.48% | -164.88% | 471.30% |
| Foreign Exchange rate Adjustments | -- | 100.00% | -131.78% | 479.41% | -102.70% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 105.76% | -699.79% | -76.72% | 862.66% | -275.18% |